Mission

You probably don’t have to look far to know someone who has been diagnosed with cancer. Every second child born today will be diagnosed with the disease sometime during their lifetime and 7 million Americans will die from it this year. At Protox, our hard work and dedication is driven by the belief that behind every statistic is a life and behind every estimate, hope. Our mission is to change these statistics for the better as we focus on developing and commercializing engineered protein toxins for the treatment of cancer and other proliferative diseases.

What's New

June 17, 2008
Protox Granted Orphan Status In Europe For Brain Cancer Treatment

May 23, 2008
Protox Completes $4.8 Million Private Placement

May 20, 2008
Protox to Present BPH Data at AUA Conference

May 15, 2008
Protox Doses First Patient In Phase 2 BPH Clinical Trial

 

Events

BioFinance
Toronto Marriott Eaton Centre Hotel (Trinity IV room) - Toronto, ON

When: May 7, 2008 10:30a.m. EDT

Presenter: Dr. Fahar Merchant, President & CEO

 

Stock Quote

LAST TRADE:$0.64
TRADE TIME:11:17AM EST
CHANGE:$-0.04 (-5.88%)
PREV CLOSE: $0.68
OPEN:$0.64
BID:$0.64
ASK:$0.72